Fig. 6

Sensitivity of Drugs in the two RM-RS Subgroups. A Drug metabolism-related gene sets enriched in the high- and low-risk subgroups (p < 0.05, false discovery rate (FDR) < 0.25). B Comparison of MSI score and exclusion score in different risk subgroups. C Sensitivity assessment of different risk subgroups for the current clinical preferred drug therapy. D, E Prediction of sensitive drugs recommended by different risk subgroups